AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
My Activity
EN
Login
EN
Surge Analysis
/
Edesa Biotech Inc.
/
2026-05-19
▲ SURGE
Edesa Biotech Inc.
+32.8%
EDSA
NASDAQ
Healthcare
2026-05-19
11.95
Close
9
Prev Close
+32.78%
Change
1.5x
Vol Ratio
Why It Surged
No related news available.
Related News
PDS Biotechnology Q1 EPS $(0.13) Beats $(0.15) Estimate - PDS Biotechnology (NASDAQ:PDSB)
Benzinga
2026-05-13
EUDA Health Holdings Receives Nasdaq Listing Notice - EUDA Health Holdings (NASDAQ:EUDA)
Benzinga
2026-04-27
Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q4 sales results and issued Q1 adjusted EPS guidance above estimates. Also, the company issued FY26 adjusted EPS guidance above estimates. - Edwards Lifesciences (NYSE:EW)
Benzinga
2026-02-10
PDS Biotech Reports First Quarter 2026 Financial Results and Provides Clinical Programs and Corporate Update
Ae.Marketscreener
2026-05-13
ADMA Biologics (NASDAQ:ADMA) Issues Quarterly Earnings Results, Meets Expectations
Marketbeat
2026-05-06
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
50.27
RSI (14)
13.55
SMA 20
6.38
Bollinger Lower
20.71
Bollinger Upper
13.55
Bollinger Mid
1.07
MACD
1.82
MACD Signal
-0.75
MACD Hist
View Company
Back to Surge Stocks
Home
Chat
Portfolio
Activity
Menu
Edesa Biotech Inc. Surged +32.8% on 2026-05-19 — Analysis | Alpha Lenz